8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 8, 2023 · 3y ago · Accession 0001576885-23-000039
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acumen Pharmaceuticals, Inc.
- Ticker
- ABOS
- CIK
- 1576885
- Form type
- 8-K
- Filing date
- Jun 8, 2023
- Report date
- Jun 6, 2023
- Document
- abos-20230606.htm
- Size
- 1.8 MB